CrossrefInfokarte
Astragaloside IV ameliorates combined allergic rhinitis and asthma syndrome by inhibiting the activation of the STAT6/GATA3/IL-4 and PI3K/AKT/NF-κB signaling pathways
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-10-29
DOI: 10.1007/s00210-026-05987-2 ↗Abstract
Kein Abstract verfügbar.
EUVIMED